Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Cipla
Express Scripts
Deloitte
Federal Trade Commission
Teva
Queensland Health
Covington

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006328

« Back to Dashboard

NDA 006328 describes ISUPREL, which is a drug marketed by Sanofi Aventis Us and Hospira and is included in four NDAs. It is available from one supplier. Additional details are available on the ISUPREL profile page.

The generic ingredient in ISUPREL is isoproterenol hydrochloride. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
Summary for 006328
Tradename:ISUPREL
Applicant:Sanofi Aventis Us
Ingredient:isoproterenol hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;RECTAL, SUBLINGUALStrength10MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;RECTAL, SUBLINGUALStrength15MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Chinese Patent Office
US Army
UBS
AstraZeneca
McKesson
Cantor Fitzgerald
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.